Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Maternal homocysteine in pregnancy and offspring birthweight: epidemiological associations and Mendelian
Chittaranjan S Yajnik1, Giriraj R Chandak2, Charudatta Joglekar3
1Diabetes Unit, King Edward Memorial Hospital and Research Centre, Pune, India, CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India, Adjunct Group Leader, Adjunct Group, Genome Institute of Singapore, Singapore, Persistent Systems Ltd, Pune, India, Department of Nutrition, University of Oslo, Oslo, Norway, Department of Pharmacology, University of Oxford, Oxford, UK, Epidemiology Research Unit, CSI Holdsworth Memorial Hospital, Mysore, India and MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK diabetes@kemdiabetes.org chandakgrc@ccmb.res.in.
Insights
High maternal homocysteine, linked to one-carbon metabolism, causally impacts fetal growth. Lowering maternal homocysteine levels may enhance fetal development and birthweight.
Area of Science:
- Nutritional biochemistry
- Maternal-fetal medicine
- Genetics
Background:
- Maternal one-carbon (1-C) metabolism disturbances are linked to poor fetal growth.
- The causal relationship between maternal 1-C metabolism and fetal growth remains unestablished.
Purpose of the Study:
- To investigate the association between maternal total homocysteine and offspring birthweight.
- To test for causality using a Mendelian randomization framework.
Main Methods:
- Studied maternal total homocysteine and offspring birthweight in Indian cohorts (Pune Maternal Nutrition Study and Parthenon Cohort Study).
- Employed Mendelian randomization with the methylenetetrahydrofolatereductase (MTHFR) gene variant rs1801133 (677C→T).
- Utilized instrumental variable and triangulation analysis, including meta-analysis.
Main Results:
- Inverse relationship observed between maternal homocysteine and offspring birthweight (meta-analysis: -40 g/SD).
- Maternal MTHFR risk genotype (rs1801133) predicted higher homocysteine and lower birthweight (meta-analysis: -61 g).
- Instrumental variable and triangulation analyses supported a causal link.
Conclusions:
- Findings suggest a causal role for maternal homocysteine in fetal growth.
- Interventions to reduce maternal homocysteine concentrations may improve fetal development.
Background:
Disturbed one-carbon (1-C) metabolism in the mother is associated with poor fetal growth but causality of this relationship has not been established.
Methods:
We studied the association between maternal total homocysteine and offspring birthweight in the Pune Maternal Nutrition Study (PMNS, Pune, India) and Parthenon Cohort Study (Mysore, India). We tested for evidence of causality within a Mendelian randomization framework, using a methylenetetrahydrofolatereductase (MTHFR) gene variant rs1801133 (earlier known as 677C→T) by instrumental variable and triangulation analysis, separately and using meta-analysis.
Results:
Median (IQR) homocysteine concentration and mean (SD) birthweight were 8.6 µmol/l (6.7,10.8) and 2642 g (379) in the PMNS and 6.0 µmol/l (5.1,7.1) and 2871 g (443) in the Parthenon study. Offspring birthweight was inversely related to maternal homocysteine concentration-PMNS: -22 g/SD [95% confidence interval (CI): (-50, 5), adjusted for gestational age and offspring gender]; Parthenon: -57 g (-92, -21); meta-analysis: -40 g (-62, -17)]. Maternal risk genotype at rs1801133 predicted higher homocysteine concentration [PMNS: 0.30 SD/allele (0.14, 0.46); Parthenon: 0.21 SD (0.02, 0.40); meta-analysis: 0.26 SD (0.14, 0.39)]; and lower birthweight [PMNS: -46 g (-102, 11, adjusted for gestational age, offspring gender and rs1801133 genotype); Parthenon: -78 g (-170, 15); meta-analysis: -61 g (-111, -10)]. Instrumental variable and triangulation analysis supported a causal association between maternal homocysteine concentration and offspring birthweight.
Conclusions:
Our findings suggest a causal role for maternal homocysteine (1-C metabolism) in fetal growth. Reducing maternal homocysteine concentrations may improve fetal growth.
More Related Videos
05:55Stable Isotope In-Vivo Labeling for Mass-Spectrometry Identification of Paternal Metabolites Transferred from Sperm to Oocyte During Fertilization
Published on: June 17, 2025
05:44Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Related Concept Videos
Teratogenicity
Development of the Oral Microbiota
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...